DNA vaccines contain instructions that teach cells how to make the COVID spike proteins so the body’s immune system can create a defense against the virus. Jet injection is pivotal to deliver the DNA vaccine into the cells of the skin or muscle – which is key to the effectiveness of the vaccine.
Why PharmaJet Needle-free jet injection?
Increased target vaccine effectiveness
- Our systems have shown improved performance with DNA vaccines over needle/syringe
Outstanding patient and caregiver experience
- Comfort and ease of use of devices means a faster adoption rate and easily integrated into healthcare systems
Proven and commercialized injection system
- Commercialized injectors lower regulatory risk and accelerates timing because we provide a proven regulatory pathway
Zydus Cadila – World’s first plasmid DNA COVID-19 vaccine
The ZyCoV-D vaccine is the first plasmid DNA vaccine approved for human use and represents a key milestone in scientific innovation and technology advancement. It is delivered intradermally using the PharmaJet Tropis® Needle-free Jet injection system exclusively which enables enhanced vaccine effectiveness.
Bionet – Asia – COVID Vaccine clinical trial
Patient enrollment has started for the Phase I trial in Australia using PharmaJet’s Needle-free Injection Systems to deliver a vaccine against SARS-CoV-2. COVIGEN, a DNA-based vaccine was developed by French-Thai pharmaceutical company BioNet-Asia. The PharmaJet System was chosen due to its record of increasing the effectiveness of DNA vaccines, ease-of-use, and speed of the delivery system compared to traditional needle and syringe.